Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study

Study acronym: ICEBERG
StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 8 of 8 entries Show 4 more changesShow less
    • Enrollment closed, study ongoing
    • Trial sites reduced: 47 → 44 locations
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 35 of 35 entries
  2. Re-verified, no change to tracked fieldsv16
  3. Study sites: 13 to 47
    • Primary and study completion dates: Mar 30, 2027 to Sep 30, 2026
    v15
  4. Primary and study completion dates: Sep 30, 2026 to Mar 30, 2027v14 Show 5 more changesShow less
    • Primary endpoints revised (8)
    • Enrollment target: 10000 to 9000
    • Study sites: 45 to 13
    • Secondary endpoints: 15 to 35
    • Study description expanded, about 82 words
  5. Study sites: 46 to 45v13
Show 11 earlier versionsHide 11 earlier versions
  1. Primary and study completion dates: Mar 31, 2026 to Sep 30, 2026
    • Secondary endpoints: details revised at 3 of 15 entries
    • Site details revised at 25 of 46 sites
    v12
  2. Study sites: 41 to 46v11
  3. 2 versions Re-verified since Mar 19, 2025, no change to tracked fieldsv9-v10
  4. Study sites: 40 to 41v8
  5. Study sites: 37 to 40v7
  6. Study sites: 32 to 37v6
  7. Study sites: 24 to 32v5
  8. Study sites: 17 to 24v4
  9. Study sites: 11 to 17v3
  10. Study sites: 1 to 11v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AstraZeneca
729 trials monitored
See 62 trials at risk
Asthma
958 trials monitored
See 36 trials at risk
This study is a multi-centre, non-interventional, observational, ambispective registry. Planned study population consists of 9 000 adult patients with uncontrolled asthma receiving treatment according to standard of care (except biologics). Planned number of study site is 70 outpatient centers with experience of uncontrolled asthma treatment in about 50 regions of Russia (in order to describe characteristics of patients with uncontrolled asthma in different regions in the most comprehensive way).
Trial Details
NCT Number NCT06521229
Lead Sponsor AstraZeneca
Conditions
(from sponsor)		 Uncontrolled Asthma
Enrollment 9,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov